Nurit Yanay
14 Kaplan Street
Petah Tiqwa, M 49202, Israel
Petah Tiqwa, M 49202, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Impaired Regeneration in Dystrophic Muscle-New Target for Therapy.
Journal: Frontiers in molecular neuroscience
Published: December 08, 2019
Improvement of motor conduction velocity in hereditary neuropathy of LAMA2-CMD dy2J/dy2J mouse model by glatiramer acetate.
Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Published: January 15, 2019
Liposomal steroid nano-drug is superior to steroids as-is in mdx mouse model of Duchenne muscular dystrophy.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: July 19, 2018
Life or death by NFκB, Losartan promotes survival in dy2J/dy2J mouse of MDC1A.
Journal: Cell death & disease
Published: November 24, 2014
Variable phenotypes of knockin mice carrying the M712T Gne mutation.
Journal: Neuromolecular medicine
Published: September 20, 2012
Nerve growth factor stimulation of ERK1/2 phosphorylation requires both p75NTR and α9β1 integrin and confers myoprotection towards ischemia in C2C12 skeletal muscle cell model.
Journal: Cellular signalling
Published: May 07, 2012
Losartan, a therapeutic candidate in congenital muscular dystrophy: studies in the dy(2J) /dy(2J) mouse.
Journal: Annals of neurology
Published: April 24, 2012
Sustained expression and safety of human GNE in normal mice after gene transfer based on AAV8 systemic delivery.
Journal: Neuromuscular disorders : NMD
Published: December 29, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026